Westover JB, Naik S, Bailey KW, Wandersee L, Gantla VR, Hickerson BT, McCormack K, Henkel G, Gowen BB. Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir. Antiviral Res. (2022) Dec;208:105444.
Gowen BB, Naik S, Westover JB, Brown ER, Gantla VR, Fetsko A, Dagley AL, Blotter DJ, Anderson N, McCormack K and Henkel G. Potent inhibition of arenavirus infection by a novel fusion inhibitor. (2021) Antiviral Res. 193 1-9.
Plewe MB, Gantlal VR, Sokolova NV, Shin YJ, Naik S, Brown ER, Fetsko A, Zhang L, Kalveram B, Freiberg AN, Henkel G and McCormack K. Discovery of a novel highly potent broad-spectrum heterocyclic chemical series of arenavirus cell entry inhibitors. (2021) Bioorg. Med. Chem. Lett., 41. DOI: 10.1016/j.bmcl.2021.127983.
Plewe MB, Sokolova NV, Gantla VR, Brown ER, Naik S, Fetsko A, Lorimer DD, Dranow DM, Smutney H, Bullen J, Sidhu R, Master A, Wang J, Kallel EA, Zhang L, Kalveram B, Freiberg AN, Henkel G and McCormack K. Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors. (2020) ACS Med. Chem. Lett., 11, 1160-1167.
Plewe MB, Whitby LR, Naik S, Brown ER, Sokolova NV, Gantla VR, York J, Nunberg JH, Zhang L, Kalveram, B,Freiberg AN, Boger DL, Henkel G, .McCormack K. SAR studies of 4-acyl- 1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors. (2019) Bioorg. Med. Chem. Lett. 29, 126620.